trial · primary record
Nab-paclitaxel in combination with pyrotinib
Early Breast Cancer
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 263 |
| Primary completion | 2026-05-15 |
| Primary endpoint | 3-year-DFS |
| Registry ID | NCT04659499 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:32.787Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04659499
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.